M33 Growth I GP LLC

Director, 10% owner at STLN

Sold, on record
$28.4M
Dollars the filings state
Form 4 sales
3
Latest Sep 4, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • STLNStarling Oncology, Inc.Director, 10% owner

Sales by reason

0
Routine
0
Plan not stated
2
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale STLNNo plan
    May 20, 2025 2025

    Sold 2M shares at $2.71 ($5.4M)

    M33 Growth I GP LLC, Director, 10% owner

    No 10b5-1 planSold 12% of holdings ($45.1M position)14.6M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale STLNNo plan
    Jun 5, 2025 +16 days

    Sold 750,000 shares at $3.05 ($2.3M)

    M33 Growth I GP LLC, Director, 10% owner

    No 10b5-1 planSold 5.1% of holdings ($44.8M position)14M shares leftFiling

  3. 3 Form 4 sale STLNUnusual
    Sep 4, 2025 +91 days

    Sold 6.7M shares at $3.09 ($20.7M)

    M33 Growth I GP LLC, Director, 10% owner

    No 10b5-1 planSold 45.8% of holdings ($45.2M position)7.9M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by M33 Growth I GP LLC
Source
Sep 4, 2025Sep 5, 2025STLNDirector, 10% ownerForm 4 sale6.7M$20.7M45.8%UnusualSEC
Jun 5, 2025Jun 9, 2025STLNDirector, 10% ownerForm 4 sale750,000$2.3M5.1%No planSEC
May 20, 2025May 22, 2025STLNDirector, 10% ownerForm 4 sale2M$5.4M12.0%No planSEC